◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
澳洋健康 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 2.0B 2.2B 2.0B 3.0B 3.1B
Revenue Growth % -7.5% 7.6% -33.3% -1.8% --
Total Revenue 2.0B 2.2B 2.0B 3.0B 3.1B
Cost Of Revenue 1.7B 1.9B 1.7B 2.8B 3.1B
+Gross Profit 269.0M 293.0M 281.0M 228.0M 15.0M
Gross Margin % 13.4% 13.5% 13.9% 7.5% 0.5%
Total Operating Cost 2.0B 2.1B 2.0B 4.2B 3.7B
Selling Expenses 42.6M 49.2M 44.8M 52.2M 55.6M
Admin Expenses 124.0M 144.0M 155.0M 329.0M 240.0M
Rd Expenses -- -- -- -- 1.3M
Finance Expenses 31.6M 32.9M 65.0M 139.0M 145.0M
+Operating Income 67.6M 82.0M 8.3M -1.1B -443.0M
Operating Margin % 3.4% 3.8% 0.4% -36.1% -14.4%
Non Operating Income 866,400 13.4M 14.8M 20.8M 23.0M
Non Operating Expenses 3.3M 25.5M 24.0M 5.9M 18.3M
Investment Income -1.3M 20.8M -15.9M -4.0M 20.5M
Fair Value Change Income -- -- -- -- 23.8M
Asset Disposal Income -59,200 29,400 -10,500 8.8M 112.0M
Asset Impairment Loss -- -- -36,000 762.0M 50.5M
Other Income 12.3M 5.1M 4.2M 38.0M 8.7M
Income Before Tax 65.2M 69.9M -964,300 -1.1B -438.0M
Income Tax 23.9M 19.7M 14.8M -11.4M 32.9M
+Net Income 41.2M 50.3M -15.7M -1.1B -471.0M
Net Margin % 2.1% 2.3% -0.8% -35.2% -15.3%
Net Income Attributable 40.6M 49.7M -15.4M -1.0B -459.0M
Minority Interest 679,100 581,800 -357,200 -28.3M -12.2M
Eps Basic 0.05 0.06 -0.02 -1.34 -0.59
Eps Diluted 0.05 0.06 -0.02 -1.34 -0.59
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 521.0M 707.0M 984.0M 983.0M 1.5B
Trading Financial Assets -- -- -- 53.2M 53.2M
Accounts Receivable 292.0M 291.0M 314.0M 1.2B 333.0M
Notes Receivable 70.5M 29.1M 204.0M 244.0M 362.0M
Notes And Accounts Receivable 362.0M 320.0M 518.0M 1.5B 695.0M
Prepayments 10.5M 19.5M 17.0M 15.4M 99.7M
Inventory 149.0M 183.0M 176.0M 165.0M 267.0M
Total Current Assets 1.1B 1.3B 1.8B 2.8B 2.9B
Long Term Equity Investment 13.6M 387,000 6.2M 10.4M 14.2M
Fixed Assets -- 716.0M 756.0M 831.0M 3.3B
Fixed Assets Total 668.0M 716.0M 756.0M 831.0M 3.3B
Construction In Progress -- 95.1M 9.0M 2.1M 5.0M
Construction In Progress Total 117.0M 95.1M 9.0M 2.1M 5.0M
Intangible Assets 63.7M 66.5M 70.4M 67.1M 165.0M
Long Term Deferred Expenses 9.4M 8.0M 10.4M 60.5M 66.2M
Total Non Current Assets 923.0M 921.0M 899.0M 1.0B 3.5B
Total Assets 2.1B 2.2B 2.7B 3.8B 6.4B
Short Term Borrowings 705.0M 1.1B 1.2B 1.4B 1.8B
Accounts Payable 356.0M 447.0M 416.0M 894.0M 1.3B
Advance Receipts 18.4M 16.0M 39.8M 15.8M 12.5M
Contract Liabilities 87.2M 39.5M 16.3M 6.0M 218.0M
Total Current Liabilities 1.7B 2.0B 2.5B 3.5B 4.7B
Long Term Borrowings 94.6M 105.0M 96.3M 125.0M 569.0M
Total Non Current Liabilities 210.0M 120.0M 181.0M 317.0M 735.0M
Total Liabilities 1.9B 2.2B 2.7B 3.8B 5.5B
Paid In Capital 766.0M 766.0M 766.0M 776.0M 776.0M
Capital Reserve 1.3B 1.3B 1.3B 1.3B 1.2B
Surplus Reserve 37.1M 37.1M 37.1M 37.1M 37.1M
Retained Earnings -1.9B -2.0B -2.0B -2.0B -968.0M
Minority Equity -19.3M -19.1M -17.4M -12.3M 16.0M
Equity Attributable 135.0M 93.9M 44.2M 63.2M 952.0M
Total Equity 115.0M 74.8M 26.8M 50.8M 968.0M
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...